JOURNAL ARTICLE
Cytarabine/daunorubicin
Year: 2022 Journal: Reactions Weekly Vol: 1911 (1)Pages: 159-159 Publisher: Adis, Springer Healthcare
Keywords:
Daunorubicin Cytarabine Pharmacology Medicine Internal medicine Leukemia
Metrics
0
Cited By
0.00
FWCI (Field Weighted Citation Impact)
1
Refs
0.11
Citation Normalized Percentile
Is in top 1%
Is in top 10%
Topics
Chronic Lymphocytic Leukemia Research
Health Sciences → Medicine → Genetics
Chemotherapy-related skin toxicity
Health Sciences → Medicine → Dermatology
Vascular Tumors and Angiosarcomas
Health Sciences → Medicine → Oncology
Related Documents
JOURNAL ARTICLE
Daunorubicin see Cytarabine/daunorubicin
Journal: Reactions Weekly Year: 1991 Vol: &NA; (354)Pages: 8-8
JOURNAL ARTICLE
Cytarabine/cytarabine/daunorubicin/etoposide
Journal: Reactions Weekly Year: 2022 Vol: 1917 (1)Pages: 201-201
JOURNAL ARTICLE
Cytarabine/daunorubicin
Journal: Reactions Weekly Year: 2022 Vol: 1926 (1)Pages: 192-192
JOURNAL ARTICLE
Cytarabine/daunorubicin
Journal: Reactions Weekly Year: 2010 Vol: &NA; (1294)Pages: 16-16
JOURNAL ARTICLE
Cytarabine/daunorubicin
Journal: Reactions Weekly Year: 2015 Vol: 1545 (1)Pages: 84-84